Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amgen
Company Monitoring Page for Amgen
latest headlines for company on cafepharma
Amgen cuts lupus programs for futility, hours after Lilly officially walks away from one too
Fierce Biotech
Fri, 04/28/23 - 10:46 am
Tags:
Amgen
,
earnings
,
Eli Lilly
,
lupus
Q1 revenues slide for Amgen, Gilead
Medical Marketing and Media
Thu, 04/27/23 - 10:54 pm
Tags:
Amgen
,
Gilead Sciences
,
earnings
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Fierce Pharma
Wed, 04/26/23 - 05:50 pm
Tags:
AbbVie
,
Amgen
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sceinces
,
JNJ
,
Merck
,
Pfizer
,
Regeneron
,
patents
,
activists
Amgen faces patent infringement claims on big-selling osteoporosis drug Evenity
Fierce Pharma
Tue, 04/25/23 - 10:10 pm
Tags:
Amgen
,
legal
,
patents
,
osteoporosis
,
Evenity
,
OssiFi-Mab
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Mon, 04/24/23 - 10:17 am
Tags:
Amgen
,
Regeneron Pharmaceuticals
,
Sanofi
,
Supreme Court
,
patents
,
Pfizer
,
Bayer
,
Roche
,
Genentech
,
AstraZeneca
,
JNJ
Finding the big spenders beyond big pharma
EP Vantage
Mon, 04/24/23 - 10:15 am
Tags:
R&D
,
Amgen
,
Bayer
,
Biogen
,
Gilead Sciences
,
Merck KGaA
,
Moderna Therapeutics
,
Novo Nordisk
,
Regeneron Pharmaceuticals
,
UCB
,
Vertex Pharmaceuticals
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D
,
AbbVie
,
Amgen
,
AstraZeneca
,
Bayer
,
Biogen
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sciences
,
GSK
,
JNJ
,
Merck
,
Merck KGaA
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
UCB
,
Vertex Pharmaceuticals
Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028
Fierce Pharma
Thu, 04/20/23 - 11:47 am
Tags:
Amgen
,
Otezla
,
immunology
,
generics
,
Sandoz
,
Zydus
,
patents
AACR: Lilly challenges Amgen, Mirati with early KRAS data, heading for a field 'much less crowded than it seems'
Fierce Biotech
Tue, 04/18/23 - 10:18 pm
Tags:
Eli Lilly
,
Amgen
,
Mirati Therapeutics
,
KRAS inhibitors
,
AACR
Biotech layoffs gather pace as industry downturn persists
BioPharma Dive
Tue, 04/11/23 - 07:18 pm
Tags:
layoffs
,
biotech
,
Amgen
,
Pfizer
,
Roche
,
Jounce Therapeutics
,
Fate Therapeutics
,
Molecular Templates
,
Sorrento Therapeutics
After 2022's M&A spree, Amgen CEO Bradway collects $21.4M payday
Fierce Pharma
Mon, 04/10/23 - 05:06 pm
Tags:
Amgen
,
Bob Bradway
,
Pharma CEOs
,
executive compensation
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Endpoints
Wed, 04/5/23 - 07:15 pm
Tags:
Amgen
,
Prolia
,
Xgeva
,
denosumab
,
clinical trials
,
NIH
,
biosimilars
,
monoclonal antibodies
Acquired patents aid J&J defense of top-selling drug from biosimilar challenge
BioPharma Dive
Wed, 03/29/23 - 03:56 pm
Tags:
Amgen
,
JNJ
,
Stelara
,
psoriasis
,
patents
,
biosimilars
AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE
Fierce Pharma
Wed, 03/29/23 - 09:58 am
Tags:
AstraZeneca
,
Amgen
,
Tezspire
,
UK
,
NICE
,
asthma
,
severe asthma
Amgen cites inflation, pressure on drug prices in 450-person layoff
Endpoints
Fri, 03/17/23 - 09:59 am
Tags:
Amgen
,
California
,
layoffs
Amgen is sued for concealing $10.7 billion tax bill from investors
Reuters
Wed, 03/15/23 - 11:11 am
Tags:
Amgen
,
taxes
,
legal
,
Puerto Rico
Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med
Fierce Biotech
Tue, 03/7/23 - 11:45 am
Tags:
Volastra Therapeutics
,
Eli Lilly
,
funding
,
sovilnesib
,
Amgen
,
cancer
Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim
Fierce Pharma
Fri, 03/3/23 - 11:56 am
Tags:
JNJ
,
patents
,
Janssen
,
Amgen
,
biosimilars
,
Stelara
Could This Humira Biosimilar Be a Winner for Amgen?
Motley Fool
Fri, 03/3/23 - 11:48 am
Tags:
Amgen
,
biosimilars
,
Amjevita
,
Humira
Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market
Fierce Biotech
Tue, 02/28/23 - 10:03 am
Tags:
Junshi Biosciences
,
Amgen
,
Sanofi
,
China
,
clinical trials
,
PCSK9 inhibitors
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.